.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Accenture
Deloitte
Fuji
Johnson and Johnson
Cantor Fitzgerald
Cipla
US Army
Daiichi Sankyo
AstraZeneca

Generated: November 18, 2017

DrugPatentWatch Database Preview

BUMEX Drug Profile

« Back to Dashboard

Which patents cover Bumex, and what generic Bumex alternatives are available?

Bumex is a drug marketed by Validus Pharms and is included in two NDAs.

The generic ingredient in BUMEX is bumetanide. There are five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-002Feb 28, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
INJECTABLE;INJECTION018226-001Feb 28, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-001Feb 28, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 1985ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BUMEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 1985► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-002Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-001Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 1985► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-001Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
INJECTABLE;INJECTION018226-001Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-002Feb 28, 1983► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
TABLET;ORAL018225-003Jun 14, 1985► Subscribe► Subscribe
Validus Pharms
BUMEX
bumetanide
INJECTABLE;INJECTION018226-001Feb 28, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Daiichi Sankyo
Medtronic
Teva
Mallinckrodt
Dow
Express Scripts
Novartis
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot